RELAPSED ACUTE MYELOID LEUKEMIA
Clinical trials for RELAPSED ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat leukemia: early trial tests Triple-Drug attack
Disease control Recruiting nowThis early-stage trial is testing a new combination of drugs for adults whose acute myeloid leukemia (AML) has returned or not responded to prior treatment. The main goals are to find safe doses and see if adding a new drug called imetelstat to standard treatments helps control t…
Matched conditions: RELAPSED ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Douglas Tremblay • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New hope for tough leukemias: testing a powerful drug cocktail
Disease control Recruiting nowThis study is testing a new combination of cancer drugs for adults with aggressive forms of acute myeloid leukemia (AML) and related blood cancers that are newly diagnosed as high-risk or have come back after previous treatment. The goal is to find the safest and most effective d…
Matched conditions: RELAPSED ACUTE MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Hope for youngest leukemia patients: new drug combo enters first safety trial
Disease control Recruiting nowThis study is testing whether adding a new drug called revumenib to two standard chemotherapy drugs is safe and effective for children and young adults with acute myeloid leukemia (AML) that has come back or hasn't responded to previous treatment. The main goal is to find the saf…
Matched conditions: RELAPSED ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New immune cell therapy tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis is a first-in-human study to test the safety and find the right dose of a new type of CAR T-cell therapy for patients with acute myeloid leukemia (AML) that has come back or not responded to other treatments. The therapy involves modifying a patient's own immune cells to tar…
Matched conditions: RELAPSED ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC